Baijin Life Science Holdings Ltd
Company Profile
Business description
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company produces health products that are affordable for the general public. The business segments of the company are Life Science segment which includes cellular technology-based services, provide including cellular drugs R&D, large molecule drugs R&D, clinical research services and R&D and sales on self-owned skincare brand, and Fine Jewelry segment that focuses on the procurement, processing, design, production and wholesale distribution of pearls and fine jewelry products.
Contact
66 Gloucester Road
Office B, 9/F Pico Tower
Wanchai
Hong Kong
HKGT: +852 36112188
Sector
Consumer Cyclical
Stock type
Cyclical
Industry
Luxury Goods
Fiscal Year End
31 March 2025
Employees
84
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,557.40 | 11.70 | -0.14% |
CAC 40 | 7,709.75 | 75.01 | 0.98% |
DAX 40 | 20,903.39 | 248.00 | 1.20% |
Dow JONES (US) | 43,487.83 | 334.70 | 0.78% |
FTSE 100 | 8,505.22 | 113.32 | 1.35% |
HKSE | 19,584.06 | 61.17 | 0.31% |
NASDAQ | 19,630.20 | 291.91 | 1.51% |
Nikkei 225 | 38,451.46 | 121.14 | -0.31% |
NZX 50 Index | 13,130.43 | 129.76 | 1.00% |
S&P 500 | 5,996.66 | 59.32 | 1.00% |
S&P/ASX 200 | 8,310.40 | 16.60 | -0.20% |
SSE Composite Index | 3,241.82 | 5.79 | 0.18% |